Back | Next |
home / stock / chma / chma message board
Subject | By | Source | When |
---|---|---|---|
Got 8,10s Stop 7,10 | europtiger | investorshub | 07/23/2019 1:57:07 PM |
Buying 8,20,s | europtiger | investorshub | 07/23/2019 1:55:36 PM |
Co reported positive results from its Phase 3 | behindthebid | investorshub | 07/23/2019 11:08:32 AM |
Chiasma management will host a conference call and | McMahon | investorshub | 07/23/2019 10:57:16 AM |
whytestocks: $CHMA News Article - NetworkNewsBreaks - Chiasma, Inc. (NASDAQ: CHMA) Closes $34.5M Off | whytestocks | investorshangout | 04/12/2019 4:15:40 PM |
well made some money from 3-4 dollars and | saigai | investorshub | 03/13/2019 1:47:20 AM |
News: $CHMA Chiasma to Participate in Three Investor | whytestocks | investorshub | 03/05/2019 12:36:50 AM |
whytestocks: $CHMA News Article - Chiasma to Participate in Three Investor Conferences in March | whytestocks | investorshangout | 03/04/2019 9:31:40 PM |
huge volume..a very strange day here | saigai | investorshub | 11/16/2018 8:08:40 PM |
non stop institutional buying..straight line share building...a robert | saigai | investorshub | 10/15/2018 6:37:43 PM |
got 3k shares here and will ad a | saigai | investorshub | 10/12/2018 3:05:45 PM |
gonna be a good day ..no one home here | saigai | investorshub | 09/24/2018 12:33:41 PM |
znewcar1: 40% .5M C1.75 solid slope up | znewcar1 | investorshangout | 08/10/2018 8:15:54 PM |
Still quiet after another 20%. This is good, | gothambio | investorshub | 09/30/2017 5:08:35 PM |
surprised so quiet on here. I guess that's | gothambio | investorshub | 09/13/2017 12:22:15 AM |
$CHMA long 1000 starter @ 1.35 beat down bio | tripil7z | investorshub | 06/15/2017 6:23:59 PM |
Revenue beat !!! | Jumboo | investorshub | 11/09/2016 10:50:10 PM |
Trading 44% lower than face value .. Even | Jumboo | investorshub | 11/02/2016 11:09:39 PM |
Nice pop today, strong move pass the 50 day | Betchips | investorshub | 09/23/2016 6:21:39 PM |
CHMA is very undervalued, considered the Cash/Book above | kany | investorshub | 07/06/2016 6:30:30 PM |
News, Short Squeeze, Breakout and More Instantly...
Pulmatrix appoints Director Anand Varadan PR Newswire LEXINGTON, Mass. , July 27, 2021 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and...
NEEDHAM, Mass., June 28, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), (“Chiasma” or the “Company”), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to improve the lives ...
NEEDHAM, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), (“Chiasma” or the “Company”) today presented patient-reported outcomes (PROs) data from its MPOWERED™ Phase 3 trial demonstrating that study patients with acromegaly reported si...